Obeidat W M, Price J C
College of Pharmacy, University of Georgia, Athens, GA 30602, USA.
J Microencapsul. 2004 Feb;21(1):47-57. doi: 10.1080/02652040310001619983.
Theophylline microspheres were prepared by the emulsion-solvent evaporation method using cellulose acetate butyrate (CAB381-20) and mixtures of CAB381-20(R) and cellulose acetate phthalate. The physical state of the drug, polymers and microspheres surfaces were determined using scanning electron microscopy. For those microspheres prepared using mixtures of CAB381-20 and cellulose acetate phthalate, scanning electron micrographs were taken before dissolution and also at different stages of dissolution (in SGF, pH 1.2 and in simulated intestinal fluid, pH 7.5). Micrographs were taken of the outside surfaces of the microspheres and of the cleaved microspheres showing their interiors (core). Drug crystals were observed on or near the surface of microspheres prepared from the polymer mixtures, while no drug particles or crystals were seen on the surfaces of microspheres prepared solely from CAB381-20. An acid wash for less than 2 min was capable of extracting all drug on the surface of the microspheres prepared from a mixture of CAB381-20 and cellulose acetate phthalate. The absence of drug crystals on the surface of CAB381-20 microspheres is believed to prevent initial drug release and create a lag time in release profiles. Results suggest that in both microsphere formulations, a layer of drug-free polymer is formed outside the core matrix and is believed to be responsible for the near zero-order release profiles.
采用醋酸丁酸纤维素(CAB381 - 20)以及CAB381 - 20(R)与邻苯二甲酸醋酸纤维素的混合物,通过乳液 - 溶剂蒸发法制备了茶碱微球。使用扫描电子显微镜确定药物、聚合物和微球表面的物理状态。对于那些使用CAB381 - 20与邻苯二甲酸醋酸纤维素混合物制备的微球,在溶解前以及溶解的不同阶段(在pH 1.2的模拟胃液和pH 7.5的模拟肠液中)拍摄扫描电子显微照片。拍摄了微球的外表面以及显示其内部(核心)的切开微球的显微照片。在由聚合物混合物制备的微球表面或其附近观察到药物晶体,而在仅由CAB381 - 20制备的微球表面未看到药物颗粒或晶体。用酸洗涤不到2分钟能够提取由CAB381 - 20与邻苯二甲酸醋酸纤维素混合物制备的微球表面上的所有药物。据信,CAB381 - 20微球表面不存在药物晶体可防止药物的初始释放并在释放曲线中产生滞后时间。结果表明,在两种微球制剂中,在核心基质外部形成了一层无药物聚合物层,据信这是导致接近零级释放曲线的原因。